Delivery Order SPE2DB22D3004-SPE2DB24FPE65
Award Date
2/2/24
Potential Completion Date
2/5/24
Potential Value
$2.5K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Cencora, Inc.
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, with an ID of SPE2DB22D3004|SPE2DB24FQE38, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract, valued at $8,136.80, is for the delivery of Meloxicam 7.5 mg tablets over a period ending on May 1, 2024. This is a firm fixed-price delivery order contract, with no set-aside designation. Amerisourcebergen Drug Corp, the prime contractor, is a major pharmaceutical distributor that specializes in...
This federal contract award, valued at $1,037.20, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of Meloxicam 15 mg tablets and has an ultimate completion date of April 3, 2024. This is a firm fixed-price delivery order contract with no set-aside designation, indicating open competition. Amerisourcebergen, a major pharmaceutical distributor and healthcare solutions provider, has a significant...
This federal contract award, valued at $23,242.03, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, as a firm fixed price delivery order. The award is for the provision of 4564235364 - MELOXICAM 15 MG TABLET 180S, a pharmaceutical product, to support military treatment programs and facilities. Amerisourcebergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA, valued at up to...
This federal contract award, with an ID of SPE2DB22D3004|SPE2DB24FPJ88, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 180 tablets of the medication Meloxicam 15 mg, with a ceiling value of $4,978.00 and a completion date of February 21, 2024. Amerisourcebergen Drug Corp is the prime contractor on this contract, which is a delivery order under a larger...
This federal contract award SPE2DB20D3104|SPE2DB25FV5N1 was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $14,053.29 firm fixed-price delivery order is for the supply of 4,567,394,067 units of the drug Meloxicam 15 mg tablets. The contract has an ultimate completion date of February 27, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order with a Firm Fixed Price pricing type, valued at $5,954.53, to provide Meloxicam 7.5 mg tablets to support military healthcare programs. The award is not associated with a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a subsidiary of the parent company...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the delivery of 4,565,244,803 units of the medication Meloxicam 7.5 mg tablets. The contract, valued at $1,266.60, has a completion date of July 26, 2024. This is a delivery order contract for the firm-fixed-price supply of this pharmaceutical product. The award is not associated with a set-aside program. AmerisourceBergen, through its...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,218.84, is for the delivery of 4,567,362,662 units of Meloxicam 15 mg tablets. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of February 25, 2025. The award is not designated as a Set-Aside contract....
This is a federal delivery order issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation's Corporate Office division. The $84,021.04 firm fixed-price contract is for the delivery of 1,000 units of the prescription drug Meloxicam 15 mg tablets. The order, which has a completion date of September 13, 2024, is not associated with a set-aside program. Amerisourcebergen is a major pharmaceutical distributor that holds several Indefinite Delivery Contracts (IDCs) with...
This federal contract award, with ID SPE2DX22D0010|SPE2D824FBM74, was issued by the Defense Logistics Agency (DLA) Medical Supply Chain to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract, with a ceiling value of $337,769.46, is a Firm Fixed Price Delivery Order with an ultimate completion date of October 25, 2023. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp, a subsidiary of the parent company...